L-tryptophan is the essential amino acid precursor to serotonin and melatonin — the "sleep and mood" amino acid. It was BANNED by the FDA from 1989-2005 after a contaminated batch from Showa Denko caused eosinophilia-myalgia syndrome (EMS), killing 37 people and disabling 1,500+. The ban was due to manufacturing contamination, NOT tryptophan itself. Since the ban's lifting, it's been safely sold again with improved manufacturing. Our research shows moderate evidence for sleep improvement (reduced sleep latency by 20 minutes) and mild depression, and it competes with 5-HTP as a serotonin precursor — tryptophan is gentler and less likely to cause serotonin syndrome but slower-acting.
Tryptophan is transported across the blood-brain barrier by the large neutral amino acid (LNAA) transporter, competing with leucine, isoleucine, valine, phenylalanine, and tyrosine. In the brain: (1) tryptophan hydroxylase (TPH2) converts tryptophan → 5-HTP; (2) aromatic amino acid decarboxylase converts 5-HTP → serotonin (5-HT); (3) in the pineal gland, serotonin → N-acetylserotonin → melatonin (via AANAT and HIOMT). Only ~1-3% of ingested tryptophan enters the serotonin pathway — the majority goes to kynurenine pathway (immune and NAD+ synthesis). Taking tryptophan with carbohydrates (without protein) increases BBB entry by 50% because insulin drives competing amino acids into muscle.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.